GEXZYNATE Trademark

Trademark Overview


On Tuesday, October 24, 2023, a trademark application was filed for GEXZYNATE with the United States Patent and Trademark Office. The USPTO has given the GEXZYNATE trademark a serial number of 98237279. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 8, 2024. This trademark is owned by Pfizer Inc.. The GEXZYNATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use
gexzynate

General Information


Serial Number98237279
Word MarkGEXZYNATE
Filing DateTuesday, October 24, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Trademark Events


Event DateEvent Description
Tuesday, October 24, 2023NEW APPLICATION ENTERED
Wednesday, January 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024NON-FINAL ACTION E-MAILED
Thursday, June 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 6, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT